Close X
Friday, November 29, 2024
ADVT 
International

Indian may face jail term for illegally re-entering US

Darpan News Desk IANS, 09 Dec, 2022 01:14 PM
  • Indian may face jail term for illegally re-entering US

Photo courtesy of IStock. 

New York, Dec 9 (IANS) An Indian national may face up to two years of imprisonment for illegally re-entering the US after he was deported from the country two years ago.

Ashok Kumar Prahladbhai Patel, 40, appeared before US Customs and Border Protection (CBP) officers on November 24, last year at the Henry E. Rohlsen Airport in St Croix for pre-boarding inspection for his flight to Fort Lauderdale, Florida.

During his inspection, Patel presented a fraudulent Florida driver's license, according to court documents.

CBP officers then conducted a database inquiry which revealed that on August 17, 2019, Patel was apprehended and detained by the CBP in Tecate, California, and was processed for expedited removal, a Department of Justice statement said.

Patel was subsequently removed from the US to India on November 21, 2019. After his removal, he did not obtain express consent of the Attorney General or the Secretary of Homeland Security to re-enter the country.

Patel's sentencing in this matter is scheduled for April 5, 2023, where he faces a term of imprisonment of up to two years. A federal district court judge will determine his sentence after considering the US Sentencing Guidelines and other factors.

MORE International ARTICLES

One person killed in shooting in Oakland

One person killed in shooting in Oakland
Police found the victim off the side of a road with apparent gunshot wounds. The man died from his injuries at the scene and his identity is being withheld until his next of kin is notified, the police said.

One person killed in shooting in Oakland

WHO calls on Pfizer to make its COVID pill more available

WHO calls on Pfizer to make its COVID pill more available
WHO Director-General Tedros Adhanom Ghebreyesus said during a news briefing that Pfizer's treatment was still too expensive. He noted that most countries in Latin America had no access to Pfizer’s drug, Paxlovid , which has been shown to cut the risk of COVID-19 hospitalization or death by up to 90%.    

WHO calls on Pfizer to make its COVID pill more available

Rare cases of COVID returning pose questions for Pfizer pill

Rare cases of COVID returning pose questions for Pfizer pill
Paxlovid has become the go-to option against COVID-19 because of its at-home convenience and impressive results in heading off severe disease. The U.S. government has spent more than $10 billion to purchase enough pills to treat 20 million people.    

Rare cases of COVID returning pose questions for Pfizer pill

CDC probing 109 liver illnesses in kids, including 5 deaths

CDC probing 109 liver illnesses in kids, including 5 deaths
About two dozen states reported suspected cases after the Centers for Disease Control and Prevention put out a call for doctors to be on the lookout for surprising cases of hepatitis. The cases date back to late October in children under 10. So far, only nine cases in Alabama have been confirmed.    

CDC probing 109 liver illnesses in kids, including 5 deaths

FDA restricts J&J's COVID-19 vaccine due to blood clot risk

FDA restricts J&J's COVID-19 vaccine due to blood clot risk
FDA officials said in a statement that they decided to restrict J&J's vaccine after taking another look at data on the risk of life-threatening blood clots within two week of vaccination.

FDA restricts J&J's COVID-19 vaccine due to blood clot risk

Omicron's latest subvariant BA.2.12.1 proves virus not declining: Report

Omicron's latest subvariant BA.2.12.1 proves virus not declining: Report
Preliminary research suggests it is about 25 per cent more transmissible than the BA.2 subvariant that is currently dominant nationally, according to the Centers for Disease Control and Prevention.

Omicron's latest subvariant BA.2.12.1 proves virus not declining: Report